Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial

Simple item page
dc.contributor.authorByakika-Kibwika, Pauline
dc.contributor.authorAchan, Jane
dc.contributor.authorLamorde, Mohammed
dc.contributor.authorKarera-Gonahasa, Carine
dc.contributor.authorKiragga, Agnes N.
dc.contributor.authorMayanja-Kizza, Harriet
dc.contributor.authorKiwanuka, Noah
dc.contributor.authorNsobya, Sam
dc.contributor.authorTalisuna, Ambrose O.
dc.contributor.authorMerry, Concepta
dc.date.accessioned2022-01-12T11:43:28Z
dc.date.available2022-01-12T11:43:28Z
dc.date.issued2017
dc.description.abstractSevere malaria is a medical emergency associated with high mortality. Adequate treatment requires initial parenteral therapy for fast parasite clearance followed by longer acting oral antimalarial drugs for cure and prevention of recrudescence. In a randomized controlled clinical trial, we evaluated the 42-day parasitological outcomes of severe malaria treatment with intravenous artesunate (AS) or intravenous quinine (QNN) followed by oral arteen_US
dc.identifier.citationByakika-Kibwika, P., Achan, J., Lamorde, M., Karera-Gonahasa, C., Kiragga, A. N., Mayanja-Kizza, H., ... & Merry, C. (2017). Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial. BMC infectious diseases, 17(1), 1-9. DOI 10.1186/s12879-017-2924-5en_US
dc.identifier.other10.1186/s12879-017-2924-5
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1222
dc.language.isoenen_US
dc.publisherBMC infectious diseasesen_US
dc.subjectArtesunateen_US
dc.subjectQuinineen_US
dc.subjectArtemisinin combination therapyen_US
dc.subjectSevere malariaen_US
dc.subjectRe-infectionen_US
dc.titleIntravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trialen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children a randomized controlled clinical trial.pdf
Size:
893.96 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences